Annual report pursuant to Section 13 and 15(d)

Net Income (Loss) Per Share (Schedule Of reconciliation of the net income (loss) per basic and diluted common share) (Details)

v3.21.2
Net Income (Loss) Per Share (Schedule Of reconciliation of the net income (loss) per basic and diluted common share) (Details) - USD ($)
 12 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Schedule of Earnings Per Share, Basic and Diluted [Line Items]    
Net (loss) income $ 7,394,374 $ (18,973,535)
Basic weighted average common shares outstanding 76,272,853 66,753,450
Common stock purchase warrants 334,206  
Total net effect of dilutive instruments 7,529,567  
Diluted weighted average common shares outstanding 83,802,420 66,753,450
Net income (loss) per basic common share outstanding $ 0.10 $ (0.28)
Net income (loss) per diluted common share outstanding $ 0.09 $ (0.28)
Stock Options [Member]    
Schedule of Earnings Per Share, Basic and Diluted [Line Items]    
Stock options 7,151,070  
Stock appreciation rights 7,151,070  
Stock Appreciation Rights (SARs) [Member]    
Schedule of Earnings Per Share, Basic and Diluted [Line Items]    
Stock options 44,291  
Stock appreciation rights 44,291